Biophysics in Drug Discovery 2017
Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs
Strasbourg, France June 6-9, 2017
Bristol-Myers-Squibb, Princeton, United States
GlaxoSmithKline, Stevenage, United Kingdom
Uppsala University, Uppsala, Sweden
Bayer, Berlin, Germany
leadXpro, Villigen, Switzerland
AstraZeneca, Macclesfield, United Kingdom
University of York & Vernalis, Cambridge, United Kingdom
Novartis, Basel, Switzerland
Boehringer Ingelheim, Biberach, Germany
NovAliX & Ribostruct, Illkirch, France